abrilada
Generic: adalimumab-afzb
Labeler: pfizer laboratories div pfizer incDrug Facts
Product Profile
Brand Name
abrilada
Generic Name
adalimumab-afzb
Labeler
pfizer laboratories div pfizer inc
Dosage Form
KIT
Manufacturer
Identifiers & Regulatory
Product NDC
0025-0328
Product ID
0025-0328_98fb6cad-18f2-4def-932e-3f4ec57cf10d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761118
Listing Expiration
2026-12-31
Marketing Start
2023-12-14
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00250328
Hyphenated Format
0025-0328
Supplemental Identifiers
RxCUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
abrilada (source: ndc)
Generic Name
adalimumab-afzb (source: ndc)
Application Number
BLA761118 (source: ndc)
Resolved Composition
Strengths
- 40 mg/0.8 ml
- 20 mg/0.4 ml
- 10 mg/0.2 ml
- 1 ml
Packaging
- 2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01)
Packages (1)
Ingredients (0)
No ingredient records.
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "98fb6cad-18f2-4def-932e-3f4ec57cf10d", "openfda": {"rxcui": ["797544", "2668064", "2668071", "2668074", "2668078", "2668095", "2668096", "2668105", "2668106", "2668109", "2668113"], "spl_set_id": ["5ef1c7cf-466f-495e-8d13-82e2ddfa7a4f"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 KIT in 1 CARTON (0025-0328-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01)", "package_ndc": "0025-0328-02", "marketing_start_date": "20231214"}], "brand_name": "ABRILADA", "product_id": "0025-0328_98fb6cad-18f2-4def-932e-3f4ec57cf10d", "dosage_form": "KIT", "product_ndc": "0025-0328", "generic_name": "adalimumab-afzb", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ABRILADA", "application_number": "BLA761118", "marketing_category": "BLA", "marketing_start_date": "20231214", "listing_expiration_date": "20261231"}